TFE3 is involved in the TGF beta signaling pathway and promotes TGF beta effects and aberrant TFE3 transcription activity is involved in the pathogenesis of alveolar soft-part sarcoma (ASPS) [23]. This evidence concerns the gene TFE3 and alveolar soft part sarcoma.